NeuroEndoNow

NeuroEndoNow features interviews, presentations and insights from researchers in the field of neuroendocrinology. A valuable resource for the neuroendocrine community.

RSS 0 0
0:00
Loading

Ep 18. IDO predicts death in NEN

Updated a long time ago.

Prof. Joerg Schefold of the Bern University Hospital, Switzerland talks about his latest publication in Neuroendocrinology - 'Increased activity of the immunoregulatory enzyme Indoleamine-2,3-dioxygenase (IDO) with consecutive tryptophan depletion predicts death in patients with neuroendocrine neoplasia"

Download

Comments